AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Enlivex Therapeutics Ltd. Report Publication Announcement 2020

Oct 22, 2020

6778_rns_2020-10-22_7b7bcba2-4122-45d8-8d47-165ad11831ab.htm

Report Publication Announcement

Opens in your device viewer

6-k false


�� "�	2 380
ENLIVEX THERAPEUTICS LTD
Corporation no: 514716489	12568
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	22/10/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-115374	Time of broadcast: 16:00 16:00

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on6-k

6KPR22102020_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 04/08/2020
Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: [email protected] Company site: www.enlivex.com

Previous names of reporting entity:

Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Einstein 14 , Ness ZIONA 3618 Telephone: 054-4617610 Facsimile: 02-6207080 E-mail: [email protected] 1
ISRAEL